These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14051905)

  • 1. ANTINEOPLASTIC AGENTS. IV. MANNICH BASE NITROGEN MUSTARDS (PART A).
    PETTIT GR; SETTEPANI JA
    J Med Pharm Chem; 1962 Mar; 5():296-302. PubMed ID: 14051905
    [No Abstract]   [Full Text] [Related]  

  • 2. POTENTIAL ANTICANCER AGENTS. IV. HETEROCYCLIC PHOSPHORAMIDE NITROGEN MUSTARDS.
    ZIMMER H; SILL AD
    Arzneimittelforschung; 1964 Feb; 14():150-1. PubMed ID: 14229652
    [No Abstract]   [Full Text] [Related]  

  • 3. A NEW BIOLOGIC REACTION OBSERVED WITH SECONDARY NITROGEN MUSTARDS NOR-HN2 (NSC-10873) AND MANNITOL MUSTARD (NSC-9698).
    WILLIAMSON CE; KIRBY JG; MILLER JI; SASS S; KRAMER SP; SELIGMAN AM; WITTEN B
    Cancer Chemother Rep; 1964 Sep; 41():47-9. PubMed ID: 14213142
    [No Abstract]   [Full Text] [Related]  

  • 4. [Structure-activity relationship in Mannich bases with and without nitrogen mustard groups and in various reduction products derived from beta-aminoketones as evidenced with the aid of a cancerostatic 3-step test using transplantation tumors].
    Werner W; Jungstand W; Gutsche W; Wohlrabe K
    Pharmazie; 1977 Jun; 32(6):341-7. PubMed ID: 896938
    [No Abstract]   [Full Text] [Related]  

  • 5. [BICYCLIC MONOPHOSPHAMIDE ESTERS AND MONOPHOSPHORIC ACID TRIAMIDES OF THE INDOLIZIDINE, QUINOLIZIDINE AND HOMOQUINOLIZIDINE TYPE WITH NITROGEN MUSTARDS IN PHOSPHAMIDE COMPOUNDS].
    WINTERFELD K; MUELLER W
    Pharm Acta Helv; 1963 Oct; 38():731-40. PubMed ID: 14097837
    [No Abstract]   [Full Text] [Related]  

  • 6. POTENTIAL ANTICANCER AGENTS. LXXIX. AROMATIC NITROGEN MUSTARDS DERIVED FROM CYSTEINE.
    IWAMOTO RH; ACTON EM; ROSS LO; SKINNER WA; BAKER BR; GOODMAN L
    J Med Chem; 1963 Jan; 6():43-6. PubMed ID: 14174029
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential anticancer agents. V. New aromatic nitrogen mustards related to 3-[N,N-bis(2-chloroethyl)amino]-4-methylbenzoic acid.
    Cambanis A; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1969 Jan; 12(1):161-4. PubMed ID: 5763014
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
    GOLD GL; SALVIN LG; SHNIDER BI
    Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670
    [No Abstract]   [Full Text] [Related]  

  • 9. A polarographic study of copper complexes with some cancer chemotherapeutic agents.
    CHRISTIAN GD; PURDY WC
    Biochim Biophys Acta; 1961 Dec; 54():587-8. PubMed ID: 13879281
    [No Abstract]   [Full Text] [Related]  

  • 10. NITROGEN MUSTARDS DERIVED FROM 3,4-DIHYDRO-2, 4-DIOXO-1(2H)-PYRIMIDINEPROPIONIC AND -BUTYRIC ACIDS.
    MARTINEZ AP; LEE WW; GOODMAN L
    J Med Chem; 1965 Mar; 8():187-9. PubMed ID: 14332657
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of nitrogen mustard on the liver, administered by the isolated perfusion technique.
    CHUNG WB; FORWARD AD; BROWN DA
    Surg Forum; 1961; 12():127-8. PubMed ID: 13879408
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.
    LASZLO J; GRIZZLE J; JONSSON U; RUNDLES RW
    Cancer Chemother Rep; 1962 Feb; 16():247-50. PubMed ID: 14462650
    [No Abstract]   [Full Text] [Related]  

  • 13. POTENTIAL ANTICANCER AGENTS. II. THE SYNTHESIS OF SOME NITROGEN MUSTARD CONTAINING SULFONES AND THIOSULFINATES.
    HIRSCH AF; PIANTADOSI C; IRVIN JL
    J Med Chem; 1965 Jan; 8():10-4. PubMed ID: 14287239
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies in the pharmacodynamics of mechlorethamine and AB 100.
    AUSMAN RK; CREVAR GE; HAGEDORN H; BARDOS TJ; AMBRUS JL
    JAMA; 1961 Nov; 178():735-8. PubMed ID: 13863314
    [No Abstract]   [Full Text] [Related]  

  • 15. CYANO ANALOGS OF PHENOLIC NITROGEN MUSTARDS.
    BURKE WJ; BROWN JE; WEATHERBEE C; CURTIS DH
    J Med Chem; 1964 Sep; 7():670-1. PubMed ID: 14233188
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance and cross-resistance of Escherichia coli mutants to anticancer agents: nitrogen mustard and nitromin.
    WOODY PL; MANDELL JD; GREENBERG J
    Radiat Res; 1961 Sep; 15():290-7. PubMed ID: 13786618
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the resistance of tumor cells to chemotherapeutic agents].
    GATI E
    Z Krebsforsch; 1960; 63():372-7. PubMed ID: 13826850
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential anticancer agents. 3. Schiff bases from benzaldehyde nitrogen mustards and aminophenylthiazoles.
    Modi JD; Sabnis SS; Deliwala CV
    J Med Chem; 1970 Sep; 13(5):935-41. PubMed ID: 5458385
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison between the hematological side effects of cyclophosphamide and nitrogen mustard.
    NISSEN-MEYER R; HOST H
    Cancer Chemother Rep; 1960 Nov; 9():51-5. PubMed ID: 13729268
    [No Abstract]   [Full Text] [Related]  

  • 20. SYNTHESIS OF N-PHOSPHORYLATED DERIVATIVES OF NITROGEN MUSTARDS WITH LATENT CYTOTOXICITY.
    FRIEDMAN OM; BOGER E; GRUBLIAUSKAS V; SOMMER H
    J Med Chem; 1963 Jan; 6():50-8. PubMed ID: 14174031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.